[HTML][HTML] Noradrenergic dysfunction in Alzheimer's and Parkinson's diseases—An overview of imaging studies
AC Peterson, CSR Li - Frontiers in Aging Neuroscience, 2018 - frontiersin.org
Noradrenergic dysfunction contributes to cognitive impairment in Alzheimer's Disease (AD)
and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance …
and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance …
Noradrenergic dysfunction in Alzheimer's and Parkinson's diseases—An overview of imaging studies.
AC Peterson, CR Li - Frontiers in Aging Neuroscience, 2018 - psycnet.apa.org
Noradrenergic dysfunction contributes to cognitive impairment in Alzheimer's Disease (AD)
and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance …
and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance …
Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases-An Overview of Imaging Studies.
AC Peterson, CR Li - Frontiers in Aging Neuroscience, 2018 - europepmc.org
Noradrenergic dysfunction contributes to cognitive impairment in Alzheimer's Disease (AD)
and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance …
and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance …
Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
AC Peterson, RL Chiang-shan - Frontiers in Aging …, 2018 - search.proquest.com
Noradrenergic dysfunction contributes to cognitive impairment in Alzheimer's Disease (AD)
and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance …
and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance …
Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases-An Overview of Imaging Studies
AC Peterson, CSR Li - Frontiers in aging neuroscience, 2018 - pubmed.ncbi.nlm.nih.gov
Noradrenergic dysfunction contributes to cognitive impairment in Alzheimer's Disease (AD)
and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance …
and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance …
[引用][C] Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
AC Peterson, RL Chiang-shan - Frontiers in Aging Neuroscience, 2018 - cir.nii.ac.jp
Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of
Imaging Studies | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …
Imaging Studies | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …
[HTML][HTML] Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
AC Peterson, RL Chiang-shan - Frontiers in Aging Neuroscience, 2018 - ncbi.nlm.nih.gov
Noradrenergic dysfunction contributes to cognitive impairment in Alzheimer's Disease (AD)
and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance …
and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance …
Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases--An Overview of Imaging Studies.
AC Peterson, CR Li - Frontiers in Aging Neuroscience, 2018 - search.ebscohost.com
Noradrenergic dysfunction contributes to cognitive impairment in Alzheimer's Disease (AD)
and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance …
and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance …